|
1.
|
Albes JM, Lietzenmayer R, Schott U,
Schülen E, Wehrmann M and Ziemer G: Improvement of non-small-cell
lung cancer staging by means of positron emission tomography.
Thorac Cardiovasc Surg. 47:42–47. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Bury T, Paulus P, Dowlati A, Corhay JL,
Weber T, Ghaye B, Schoffers J, Limet R, Albert A, Rigo P and
Radermecker M: Staging of the mediastinum: value of positron
emission tomography imaging in non-small cell lung cancer. Eur
Respir J. 9:2560–2564. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Coleman RE: PET in lung cancer. J Nucl
Med. 40:814–820. 1999.PubMed/NCBI
|
|
4.
|
Sachs S and Bilfinger TV: The impact of
positron emission tomography on clinical decision making in a
university-based multidisciplinary lung cancer practice. Chest.
128:698–703. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Gould MK, Maclean CC, Kuschner WG, Rydzak
CE and Owens DK: Accuracy of positron emission tomography for
diagnosis of pulmonary nodules and mass lesions: a meta-analysis.
JAMA. 285:914–924. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Gould MK, Kuschner WG, Rydzak CE, Maclean
CC, Demas AN, Shigemitsu H, Chan JK and Owens DK: Test performance
of positron emission tomography and computed tomography for
mediastinal staging in patients with non-small-cell lung cancer: a
meta-analysis. Ann Intern Med. 139:879–892. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Toloza EM, Harpole L and McCrory DC:
Noninvasive staging of non-small cell lung cancer: a review of the
current evidence. Chest. 123:S137–S146. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Sasaki M, Ichiya Y, Kuwabara Y, Akashi Y,
Yoshida T, Fukumura T, Murayama S, Ishida T, Sugio K and Masuda K:
The usefulness of FDG positron emission tomography for the
detection of mediastinal lymph node metastases in patients with
non-small cell lung cancer: a comparative study with X-ray computed
tomography. Eur J Nucl Med. 23:741–747. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Sazon DA, Santiago SM, Soo Hoo GW,
Khonsary A, Brown C, Mandelkern M, Blahd W and Williams AJ:
Fluorodeoxyglucose-positron emission tomography in the detection
and staging of lung cancer. Am J Respir Crit Care Med. 153:417–421.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Vansteenkiste JF and Stroobants SG: The
role of positron emission tomography with
18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J.
17:802–820. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Valk PE, Pounds TR, Hopkins DM, Haseman
MK, Hofer GA, Greiss HB, Myers RW and Lutrin CL: Staging non-small
cell lung cancer by whole-body positron emission tomographic
imaging. Ann Thorac Surg. 60:1573–1582. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Vansteenkiste JF, Stroobants SG, De Leyn
PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL,
Verschakelen JA, Lerut TE, Mortelmans LA and Demedts MG: Lymph node
staging in non-small-cell lung cancer with FDG-PET scan: a
prospective study on 690 lymph node stations from 68 patients. J
Clin Oncol. 16:2142–2149. 1998.PubMed/NCBI
|
|
13.
|
Patz EF Jr, Lowe VJ, Goodman PC and
Herndon J: Thoracic nodal staging with PET imaging with 18FDG in
patients with bronchogenic carcinoma. Chest. 108:1617–1621. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Pieterman RM, van Putten JW, Meuzelaar JJ,
Mooyaart EL, Vaalburg W, Koëter GH, Fidler V, Pruim J and Groen HJ:
Preoperative staging of non-small-cell lung cancer with
positron-emission tomography. N Engl J Med. 343:254–261. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Scott WJ, Gobar LS, Terry JD, Dewan NA and
Sunderland JJ: Mediastinal lymph node staging of non-small-cell
lung cancer: a prospective comparison of computed tomography and
positron emission tomography. J Thorac Cardiovasc Surg.
111:642–648. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Nomori H, Watanabe K, Ohtsuka T, Naruke T,
Suemasu K and Uno K: The size of metastatic foci and lymph nodes
yielding false-negative and false-positive lymph node staging with
positron emission tomorgraphy in patients with lung cancer. J
Thorac Cardiovasc Surg. 127:1087–1092. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Steinert HC, Hauser M, Allemann F, Engel
H, Berthold T, von Schulthess GK and Weder W: Non-small cell lung
cancer: nodal staging with FDG PET versus CT with correlative lymph
node mapping and sampling. Radiology. 202:441–446. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wahl RL, Quint LE, Greenough RL, Meyer CR,
White RI and Orringer MB: Staging of mediastinal non-small cell
lung cancer with FDG PET, CT, and fusion images: preliminary
prospective evaluation. Radiology. 191:371–377. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hagberg RC, Segall GM, Stark P, Burdon TA
and Pompili MF: Characterization of pulmonary nodules and
mediastinal staging of bronchogenic carcinoma with F-18
fluorodeoxyglucose positron emission tomography. Eur J Cardiothorac
Surg. 12:92–97. 1997. View Article : Google Scholar
|
|
20.
|
Gupta NC, Tamim WJ, Graeber GG, Bishop HA
and Hobbs GR: Mediastinal lymph node sampling following positron
emission tomography with fluorodeoxyglucose imaging in lung cancer
staging. Chest. 120:521–527. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dunagan D, Chin R Jr, McCain T, Case L,
Harkness B, Oaks T and Haponik E: Staging by positron emission
tomography predicts survival in patients with non-small cell lung
cancer. Chest. 119:333–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Lavrenkov K, Partridge M, Cook G and Brada
M: Positron emission tomography for target volume definition in the
treatment of non-small cell lung cancer. Radiother Oncol. 77:1–4.
2005.PubMed/NCBI
|
|
23.
|
Greene FL; American Joint Committee on
Cancer, American Cancer Society: AJCC Cancer Staging Manual. 6th
edition. Springer-Verlag; New York: 2002, View Article : Google Scholar
|
|
24.
|
Fleiss JL: Statistical Methods for Rates
and Proportions. 2nd edition. John Wiley and Sons, Inc; New York:
1981
|
|
25.
|
Bradley JD, Wahab S, Lockett MA, Perez CA
and Purdy JA: Elective nodal failures are uncommon in medically
inoperable patients with stage I non-small-cell lung carcinoma
treated with limited radio-therapy fields. Int J Radiat Oncol Biol
Phys. 56:342–347. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Rosenzweig KE, Sura S, Jackson A and Yorke
E: Involved-field radiation therapy for inoperable non small-cell
lung cancer. J Clin Oncol. 25:5557–5561. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, Li
J, Liu X, Wang R, Li B, Kong L and Yin Y: A randomized study of
involved-field irradiation versus elective nodal irradiation in
combination with concurrent chemotherapy for inoperable stage III
nonsmall cell lung cancer. Am J Clin Oncol. 30:239–244. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Van Tinteren H, Hoekstra OS, Smit EF, van
den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans
EF, Diepenhorst FW, Verboom P, van Mourik JC, Postmus PE, Boers M
and Teule GJ: Effectiveness of positron emission tomography in the
preoperative assessment of patients with suspected non-small-cell
lung cancer: the PLUS multi-centre randomized trial. Lancet.
359:1388–1393. 2002.PubMed/NCBI
|
|
29.
|
Viney RC, Boyer MJ, King MT, Kenny PM,
Pollicino CA, McLean JM, McCaughan BC and Fulham MJ: Randomized
controlled clinical trial of the role of positron emission
tomography in the management of stage I and II non-small-cell lung
cancer. J Clin Oncol. 22:2357–2362. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Fischer B, Lassen U, Mortensen J, et al:
Preoperative staging of lung cancer with combined PET-CT. N Engl J
Med. 361:32–39. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
López-Encuentra A, García-Luján R, Rivas
JJ, Rodríguez-Rodríguez J, Torres-Lanza J and Varela-Simo G;
Bronchogenic Carcinoma Cooperative Group of the Spanish Society of
Pneumology and Thoracic Surgery: Comparison between clinical and
pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg.
79:974–979. 2005.PubMed/NCBI
|
|
32.
|
Fernando HC and Goldstraw P: The accuracy
of clinical evaluative intrathoracic staging in lung cancer as
assessed by postsurgical pathologic staging. Cancer. 65:2503–2506.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Gdeedo A, van Schil P, Corthouts B, van
Mieghem F, van Meerbeeck J and van Marck E: Comparison of imaging
TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic
carcinoma. Eur J Cardiothorac Surg. 12:224–227. 1997.
|
|
34.
|
Bülzebruck H, Bopp R, Drings P, Bauer E,
Krysa S, Probst G, van Kaick G, Müller KM and Vogt-Moykopf I: New
aspects in the staging of lung cancer. Prospective validation of
the International Union Against Cancer TNM classification. Cancer.
70:1102–1110. 1992.PubMed/NCBI
|
|
35.
|
Bülzebruck H, Drings P, Kayser K, Schulz
V, Tuengerthal S and Vogt-Moykopf I: Classification of lung cancer:
first experiences with the new TNM classification (4th edition).
Eur Respir J. 4:1197–1206. 1991.PubMed/NCBI
|
